.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
LMFAO Cannabis is stocked at 92 licensed dispensaries across California, with the deepest coverage in Los Angeles, Sacramento, San Jose, San Diego, and Santa Rosa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, LMFAO Cannabis tilted its mix toward Concentrates at 37.20% share with year-over-year growth of 26.86% and month-over-month growth of 7.01%, while Flower held 36.97% share but contracted year-over-year by 38.43% despite a 43.23% month-over-month rebound; the surge in Pre-Roll to 18.50% share came with a 1,655.44% year-over-year jump but a 25.66% month-over-month pullback, and Vapor Pens at 7.33% share fell 54.44% year-over-year even as they rose 6.52% month-over-month. With average price down 33.19% year-over-year and total brand sales down 6.12% year-over-year, this pattern implies the brand is using price to accelerate volume in Concentrates and Pre-Roll while absorbing a structural reset in Flower and Vapor Pens, concentrating bets where short-cycle momentum (43.23% MoM in Flower and 7.01% MoM in Concentrates) can offset longer-term category drag.
Positioning-wise, anchoring 37.20% of sales in Concentrates while ranking 36th in Concentrates in California suggests headroom if the 7.01% month-over-month gain compounds faster than the 38.43% year-over-year decline in Flower, because the two categories together represent 74.17% of the mix. The juxtaposition of a 1,655.44% year-over-year expansion in Pre-Roll against a 25.66% month-over-month retreat signals trial-heavy volatility rather than stable retention, implying the brand should lean on Concentrates’ steadier month-over-month trend and the 6.52% month-over-month lift in Vapor Pens to diversify risk while using the 33.19% year-over-year price reduction to defend share without overexposing the portfolio to Pre-Roll swings.
Competitive Landscape
LMFAO Cannabis sits at rank 36 in CA Concentrates in September 2026, improving 12 positions from rank 48 year over year, and also rising 13 spots from rank 49 three months prior; against a longer arc, the brand remains 12 ranks below its May 2025 peak at rank 24, indicating recovery rather than full re-attainment. Competitive pressure intensified as Raw Garden held rank 1 with a 9.4% year-over-year sales increase while 710 Labs advanced from rank 4 to rank 2 alongside a 32.7% sales lift, whereas Punch Extracts / Punch Edibles slipped from rank 3 to rank 4 with a 7.7% sales decline, suggesting LMFAO Cannabis’s climb occurred amid both accelerating leaders and softening mid-tier rivals. The rank trajectory—double-digit gains over both the year (+12) and quarter (+13) but still trailing the prior peak by 12 ranks—implies progress tied to short-term execution rather than category leadership, with further share capture required to convert momentum into sustained top-25 presence.
Notable Products
Maui Wowie Pre-Roll (1g) posted the sharpest movement in September 2026 with a -60.96% month-over-month change while slipping to rank 9, whereas Ice Cream Cake Pre-Roll (1g) fell -42.78% but still held rank 1. Sour Tangie Pre-Roll (1g) rose 30.07% to rank 4 as Cherry Ember Pre-Roll (1g) declined -14.15% at rank 7, and five of the top ten are Pre-Roll SKUs, indicating volatility concentrated in a single format. With Concentrates occupying ranks 5, 6, 8, and 10 and one Live Resin SKU generating $14,123, the mix points to a pivot from volume-heavy Pre-Rolls toward steadier Live Resin placement. The pattern implies LMFAO Cannabis is relying on Concentrates to stabilize rank positions as Pre-Roll demand swings widen, suggesting near-term assortment and promo focus should rebalance Pre-Rolls while protecting Live Resin rank density.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
